In a 67‑year‑old female with hypertension, arthritis, and gout on losartan, amlodipine, colchicine, and etoricoxib, presenting with recent melena, progressive generalized weakness, constipation, epigastric pain, light‑headedness, and a brief loss of consciousness, what is the primary working impression and three appropriate differential diagnoses?

Primary Working Impression: Acute Upper Gastrointestinal Bleeding with Hemorrhagic Shock and Syncope

This 67-year-old woman presenting with melena, progressive weakness, syncope, and epigastric pain most likely has acute upper gastrointestinal bleeding complicated by hemorrhagic shock, with her loss of consciousness representing syncope from hypovolemia rather than a primary neurologic or cardiac event. 1

Clinical Reasoning

Supporting Evidence for GI Bleeding as Primary Diagnosis

• The black, wet stool three days prior to admission represents melena, indicating upper GI bleeding with blood transit time sufficient for degradation (general medical knowledge)
• Progressive generalized weakness over three days followed by syncope is the classic presentation of ongoing blood loss leading to hypovolemia and orthostatic hypotension 1
• Epigastric pain worsening after eating strongly suggests a gastric or duodenal source (general medical knowledge)
• Pale palpebral conjunctiva on examination confirms significant anemia from blood loss (general medical knowledge)
• The patient's medication regimen includes multiple risk factors: etoricoxib (COX-2 inhibitor) at 120 mg daily for gout increases GI bleeding risk, and losartan/amlodipine for hypertension may mask compensatory tachycardia 2, 3

Syncope Mechanism

• Syncope in older adults frequently results from orthostatic hypotension, particularly when compounded by blood loss and dehydration 1
• The unwitnessed brief loss of consciousness with spontaneous recovery and no post-event confusion is consistent with vasovagal or orthostatic syncope rather than seizure 4
• Absence of tongue bite, urinary incontinence, prolonged confusion (>30 seconds), or witnessed abnormal movements argues strongly against seizure/Todd's paralysis 4
• The transient speech difficulty two days prior ("blanking out" while maintaining awareness) likely represents presyncope from cerebral hypoperfusion rather than a true TIA, given the context of ongoing blood loss 4

Medication-Related Considerations

• Etoricoxib, a COX-2 selective NSAID, carries significant GI bleeding risk even with its improved safety profile compared to non-selective NSAIDs 3
• Colchicine in this patient with likely volume depletion and possible renal hypoperfusion from bleeding poses risk for myotoxicity, though her current symptoms are more consistent with hypovolemia than colchicine toxicity 5, 6
• Losartan and amlodipine may contribute to orthostatic symptoms, particularly in the setting of volume depletion 2

Three Differential Diagnoses

1. NSAID-Induced Peptic Ulcer with Hemorrhage

• Etoricoxib use for gout, even as a COX-2 selective agent, significantly increases peptic ulcer risk, particularly in elderly patients 3, 7
• Epigastric pain worsening after meals is classic for gastric or duodenal ulceration (general medical knowledge)
• The combination of chronic NSAID use with hypertension medications in a geriatric patient creates a high-risk profile for complicated ulcer disease 7
• This is the most likely specific etiology given the medication history and symptom pattern 3

2. Colchicine-Induced Myopathy with Concurrent GI Bleeding

• Progressive generalized weakness and reported "quadriplegia" could represent colchicine myotoxicity, which presents with proximal muscle weakness and generalized weakness 6
• Colchicine myotoxicity typically occurs days to weeks after initiation or dose increase, particularly in patients with renal impairment or on interacting medications 6
• However, the absence of muscle tenderness on examination (abdomen described as non-tender, extremities without documented tenderness) and the presence of melena make primary GI bleeding more likely 6
• Colchicine toxicity often presents with gastrointestinal symptoms (anorexia, diarrhea), but this patient has constipation, making this diagnosis less likely as the primary process 5, 6
• If present, this would be a secondary complicating factor rather than the primary diagnosis 6

3. Cardiac Syncope from Arrhythmia or Structural Heart Disease

• Syncope in a 67-year-old with hypertension and cardiovascular risk factors warrants consideration of cardiac causes 1
• The ACC/AHA guidelines emphasize that older adults with syncope require comprehensive cardiovascular evaluation including ECG and orthostatic vital signs 1
• However, the clear temporal relationship between melena onset and progressive symptoms, combined with pale conjunctiva, makes hemorrhagic shock the more likely mechanism 1
• Cardiac syncope typically presents with sudden onset without prodrome, whereas this patient had three days of progressive symptoms 1
• The brief, self-limited nature with full recovery and no recurrence during hospitalization argues against high-grade AV block or ventricular arrhythmia 1

Critical Pitfalls to Avoid

• Do not attribute the "quadriplegia" report to a neurologic event without first correcting severe anemia—profound weakness from anemia can mimic neurologic deficits (general medical knowledge)
• Do not delay upper endoscopy while pursuing extensive neurologic workup when melena and anemia are present (general medical knowledge)
• Recognize that syncope in the elderly is often multifactorial, but identifying the primary trigger (in this case, hypovolemia from GI bleeding) is essential for appropriate management 1
• Do not continue etoricoxib in a patient with suspected or confirmed peptic ulcer disease—immediate discontinuation is mandatory 3, 7
• Adjust colchicine dosing or discontinue if renal function is impaired, as the patient may have prerenal azotemia from volume depletion 5, 6